Consider Offering CGM Earlier for Diabetes

April 2026

You’ll see a shift toward earlier use of continuous glucose monitoring (CGM) devices in patients with diabetes.

Am Diabetes Assoc (ADA) guidelines now recommend CGM at diagnosis or anytime after for patients on insulin or other meds that can cause hypoglycemia (glipizide, etc)...or whenever CGM can help with management.

That’s because early initiation is associated with benefits such as improved A1c, increased time in range (TIR), and reduced hypoglycemia.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

  • Cutting-edge advice about new medications and how they fit into practice
  • Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
  • Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote